Goldman Sachs’s SOC Telemed, Inc. Class A Common Stock TLMD Stock Holding History

Goldman Sachs’s Portfolio TLMD Stock Details TLMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-37,877	Closed	-$113K	–	6951
2022 Q1	$113K	Sell	37,877 -60,719	-62%	-$134K	﹤0.01%	6074
2021 Q4	$126K	Buy	98,596 +87,825	+815%	+$176K	﹤0.01%	6071
2021 Q3	$24K	Buy	+10,771	New	+$38.7K	﹤0.01%	6138
2021 Q2	–	Sell	-40,105	Closed	-$252K	–	6731
2021 Q1	$252K	Buy	40,105 +7,778	+24%	+$58.4K	﹤0.01%	5519
2020 Q4	$253K	Sell	32,327 -117,673	-78%	-$1.04M	﹤0.01%	4974
2020 Q3	$1.52M	Buy	+150,000	New	+$1.55M	﹤0.01%	3774

Goldman Sachs's TLMD Position: Q2 2022 in Review

Goldman Sachs sold out of SOC Telemed, Inc. Class A Common Stock (TLMD) in Q2 2022, closing a stake of 37,877 shares — an estimated $113K sold.

Goldman Sachs first reported a position in TLMD in Q3 2020 and held it in 6 quarters. The position peaked at $1.52M in Q3 2020. 0 funds tracked by Wall St. Rank hold TLMD as of Q2 2022.

Goldman Sachs reported no remaining SOC Telemed, Inc. Class A Common Stock position as of Q2 2022 after selling out during the quarter.
Goldman Sachs sold 37,877 SOC Telemed, Inc. Class A Common Stock shares in Q2 2022, an estimated $113K.
Goldman Sachs first reported a position in SOC Telemed, Inc. Class A Common Stock in Q3 2020 and held it in 6 quarters.
Goldman Sachs's SOC Telemed, Inc. Class A Common Stock position peaked at $1.52M in Q3 2020.
0 funds tracked by Wall St. Rank held SOC Telemed, Inc. Class A Common Stock as of Q2 2022.

Based on Goldman Sachs's 13F filing for Q2 2022, filed 15 Aug 2022.